James L Tyree
CIK 1324991 · Executive Vice President · last filed 2025-08-29
James L Tyree is an Executive Vice President who has filed 67 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for GNLX, was dated Aug 29, 2025. Across all open-market trades the lifetime net is −$19.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.23M
7
67
-$19.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNLX | Director | 68,074 | $2.96 | $201.5K | -$132.0K | 10 | 2025-08-29 |
| ASRT | Director | 188,251 | $23.48 | $4.42M | -$375.4K | 8 | 2024-03-15 |
| CCXI | Director | 0 | $10.22 | $0 | -$3.17M | 18 | 2022-10-24 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 3 | 2018-05-10 |
| INVA | Director | 70,554 | $22.74 | $1.60M | -$8.5K | 3 | 2017-04-24 |
| Innoviva, Inc. (THRX) Delisted | Director | 33,182 | $4.06 | $134.7K | -$41.1K | 3 | 2015-06-04 |
| ABBOTT LABORATORIES (ABTw) Delisted | Executive Vice President | 134,575 | — | — | -$15.77M | 22 | 2009-03-03 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-29 | GNLX | Grant (A) | +22,283 | $0 | EDGAR |
| 2024-12-31 | GNLX | Grant (A) | — | $0 | EDGAR |
| 2024-12-30 | GNLX | Sell (S) | −3,460 | -$8.5K | EDGAR |
| 2024-09-26 | GNLX | — | — | $0 | EDGAR |
| 2024-09-12 | GNLX | Sell (S) | −1,730 | -$4.5K | EDGAR |
| 2024-08-05 | GNLX | Grant (A) | +39,541 | $0 | EDGAR |
| 2024-06-07 | GNLX | Buy (P) | +6,250 | $0 | EDGAR |
| 2024-03-15 | ASRT | Sell (S) | −10,251 | -$11.5K | EDGAR |
| 2023-12-14 | GNLX | Sell (S) | −9,000 | -$119.0K | EDGAR |
| 2023-09-13 | GNLX | Grant (A) | +3,460 | $0 | EDGAR |